Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Toward personalized cancer nanomedicine-past, present, and future
Alexander H. Stegh
*
*
Corresponding author for this work
Neurology
Research output
:
Contribution to journal
›
Review article
›
peer-review
41
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Toward personalized cancer nanomedicine-past, present, and future'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Biochemistry, Genetics and Molecular Biology
Oncogene
100%
Tumor Gene
100%
Small Molecule
50%
RNA Interference
50%
Drug Mechanism
50%
Genetics
50%
Proteomics
50%
Gene Function
50%
Medicine and Dentistry
Malignant Neoplasm
100%
Nanomedicine
100%
Neoplasm
71%
Tumor Gene
28%
Biological Marker
14%
Therapeutic Agent
14%
Pathophysiology
14%
Treatment Response
14%
Proteomics
14%
Gene Function
14%
RNA Interference
14%
Drug Action
14%
Clinical Endpoint
14%
Early Diagnosis
14%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Nanomedicine
100%
Neoplasm
62%
Drug Development
12%
Biological Marker
12%
Multiple Cancer
12%
Pathophysiology
12%
Drug Action
12%
Keyphrases
Cancer Nanomedicine
100%
Biomarkers for Early Diagnosis
33%
Reversible Modification
33%
Personalized Nanomedicine
33%
Irreversible Transformation
33%